These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22681167)

  • 1. Epigenetics, depression and antidepressant treatment.
    Menke A; Klengel T; Binder EB
    Curr Pharm Des; 2012; 18(36):5879-89. PubMed ID: 22681167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations in depression and antidepressant treatment.
    Menke A; Binder EB
    Dialogues Clin Neurosci; 2014 Sep; 16(3):395-404. PubMed ID: 25364288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modifications of Major Depressive Disorder.
    Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
    Paoli C; Misztak P; Mazzini G; Musazzi L
    Curr Neuropharmacol; 2022 Nov; 20(12):2267-2291. PubMed ID: 35105292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
    Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
    Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic aging in major depressive disorder: Clocks, mechanisms and therapeutic perspectives.
    Shaikh M; Doshi G
    Eur J Pharmacol; 2024 Sep; 978():176757. PubMed ID: 38897440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epigenetic mechanisms in major depression].
    Paslakis G; Bleich S; Frieling H; Deuschle M
    Nervenarzt; 2011 Nov; 82(11):1431-2, 1434-8. PubMed ID: 21264459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
    Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
    Deussing JM; Jakovcevski M
    Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation in Major Depressive Disorder.
    Pishva E; Rutten BPF; van den Hove D
    Adv Exp Med Biol; 2017; 978():185-196. PubMed ID: 28523547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epigenetic mechanism of major depression].
    Morinobu S
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1101-12. PubMed ID: 24450142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models.
    Chistiakov DA; Bobryshev YV; Chekhonin VP
    Curr Pharm Des; 2017; 23(44):6828-6840. PubMed ID: 29086676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in major depressive disorder: From pathophysiology to therapy.
    Gonda X; Petschner P; Eszlari N; Baksa D; Edes A; Antal P; Juhasz G; Bagdy G
    Pharmacol Ther; 2019 Feb; 194():22-43. PubMed ID: 30189291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
    Islam F; Gorbovskaya I; Müller DJ
    Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.